Sanara MedTech (SMTI) Depreciation & Amortization (CF) (2010 - 2026)

Sanara MedTech's Depreciation & Amortization (CF) history runs 16 years deep, the most recent figure standing at $587252.0 for Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 47.77% year-over-year to $587252.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (down 31.03% YoY) and the FY2025 annual result came in at $3.9 million, down 19.85% from the prior year.
• Depreciation & Amortization (CF) was $587252.0 for Q1 2026 at Sanara MedTech, down from $668396.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $1.6 million in Q4 2024 and bottomed at $202747.0 in Q1 2022.
• A 5-year average of $911913.8 and a median of $997674.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 434.81% — and 2025, when it tumbled 58.44%.
• Sanara MedTech's Depreciation & Amortization (CF) stood at $814316.0 in 2022, then jumped by 34.44% to $1.1 million in 2023, then jumped by 46.92% to $1.6 million in 2024, then tumbled by 58.44% to $668396.0 in 2025, then fell by 12.14% to $587252.0 in 2026.
• Business Quant data shows SMTI's Depreciation & Amortization (CF) at $587252.0 in Q1 2026, $668396.0 in Q4 2025, and $1.0 million in Q3 2025.